Cello Health PLC Block Listing Update (5159K)
December 14 2018 - 4:24AM
UK Regulatory
TIDMCLL
RNS Number : 5159K
Cello Health PLC
14 December 2018
14 December 2018
Cello Health plc
("Cello" or the "Company")
Block Listing Update
Further to the announcement by the Company on 5 June 2018, the
Company announces that a total of 51,988 new ordinary shares of 10p
each in the share capital of the Company ("Ordinary Shares") have
been issued and allotted since that date pursuant to the Company's
PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its
Unapproved Scheme 2010 and admitted to trading in accordance with
the block listing applied for at that time (the "Block Listing").
An update in accordance with Schedule 6 of the AIM Rules for
Companies is set out below.
Enquires
Cello Health 020 7812 8460
Mark Scott, Chief Executive
Mark Bentley, Finance Director
Cenkos Securities 020 7397 8900
Mark Connelly
Harry Hargreaves
BLOCK LISTING SIX MONTHLY RETURN
Name of applicant: Cello Health plc
Name of scheme: PSP Option Scheme 2010, Approved
Share Option Plan 2009 and Unapproved
Scheme 2010
-------------------------------------------
Period of return: From: 31 May 2018 To: 31 November 2018
-------- --------------- ---- --------------------
Balance of unallotted securities
under scheme(s) from previous
return: 663,596
-------------------------------------------
Plus: The amount by which the -
block scheme(s) has been increased
since the date of the last
return (if any increase has
been applied for):
-------------------------------------------
Less: Number of securities
issued/allotted under scheme(s)
during period (see LR3.5.7G): (51,988)
-------------------------------------------
Equals: Balance under scheme(s)
not yet issued/allotted at
end of period: 611,608
-------------------------------------------
Name of contact: Mark Bentley, Group Finance Director
-------------------------------------------
Telephone number of contact: 020 7812 8460
-------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BLRZMMMZLDZGRZG
(END) Dow Jones Newswires
December 14, 2018 04:24 ET (09:24 GMT)
Cello Health (LSE:CLL)
Historical Stock Chart
From Apr 2024 to May 2024
Cello Health (LSE:CLL)
Historical Stock Chart
From May 2023 to May 2024